Liu R, Tang L, Liu Y, Hu H, Liu J
BMC Cancer. 2025; 25(1):387.
PMID: 40033246
PMC: 11877943.
DOI: 10.1186/s12885-025-13576-4.
Zhu X, Yuan F, Sun Q, Yang C, Jiang H, Xiang X
J Neurooncol. 2025; .
PMID: 39954037
DOI: 10.1007/s11060-025-04971-9.
Mella C, Tsarouhas P, Brockwell M, Ball H
Cancers (Basel). 2025; 17(1.
PMID: 39796780
PMC: 11719864.
DOI: 10.3390/cancers17010154.
He S, Zheng L, Qi C
Mol Cancer. 2025; 24(1):5.
PMID: 39780248
PMC: 11707952.
DOI: 10.1186/s12943-024-02208-3.
Li G, Che X, Wang S, Liu D, Xie D, Jiang B
Ann Med. 2025; 57(1):2447403.
PMID: 39757995
PMC: 11705547.
DOI: 10.1080/07853890.2024.2447403.
IL-17 signaling protects against induced gastric cancer.
Brackman L, Jung M, Green E, Joshi N, Revetta F, McClain M
Gut Microbes. 2024; 16(1):2430421.
PMID: 39588838
PMC: 11639209.
DOI: 10.1080/19490976.2024.2430421.
How lactate affects immune strategies in lymphoma.
Zhou Y, Lou J, Tian Y, Ding J, Wang X, Tang B
Front Mol Biosci. 2024; 11:1480884.
PMID: 39464313
PMC: 11502318.
DOI: 10.3389/fmolb.2024.1480884.
Research status and development trends of omics in neuroblastoma a bibliometric and visualization analysis.
Han M, Niu H, Duan F, Wang Z, Zhang Z, Ren H
Front Oncol. 2024; 14:1383805.
PMID: 39450262
PMC: 11499224.
DOI: 10.3389/fonc.2024.1383805.
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?.
Du R, Zhang J, Lukas R, Tripathi S, Ahrendsen J, Curran M
Neuro Oncol. 2024; 27(1):33-49.
PMID: 39427326
PMC: 11726257.
DOI: 10.1093/neuonc/noae193.
Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment.
Ghebremedhin A, Athavale D, Zhang Y, Yao X, Balch C, Song S
Cancers (Basel). 2024; 16(19).
PMID: 39410029
PMC: 11475569.
DOI: 10.3390/cancers16193410.
TRIP13: A promising cancer immunotherapy target.
Jing S, Zhao L, Zhao L, Gao Y, He T
Cancer Innov. 2024; 3(6):e147.
PMID: 39398261
PMC: 11467489.
DOI: 10.1002/cai2.147.
Prognostic Significance and Immune Landscape of an Efferocytosis-Related Gene Signature in Bladder Cancer.
Zheng F, Wang Z, Dong Q, Li S, Xiong S, Yuan Y
Biochem Genet. 2024; .
PMID: 39313721
DOI: 10.1007/s10528-024-10924-0.
IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma.
Xing Z, Li X, He Z, Fang X, Liang H, Kuang C
Pharmaceutics. 2024; 16(7).
PMID: 39065567
PMC: 11279595.
DOI: 10.3390/pharmaceutics16070870.
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.
Campanelli R, Carolei A, Catarsi P, Abba C, Boveri E, Paulli M
Cancers (Basel). 2024; 16(14).
PMID: 39061196
PMC: 11275082.
DOI: 10.3390/cancers16142556.
The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies.
Hu M, Deng F, Song X, Zhao H, Yan F
J Exp Clin Cancer Res. 2024; 43(1):190.
PMID: 38987821
PMC: 11234789.
DOI: 10.1186/s13046-024-03115-7.
A cellular senescence-related signature for predicting prognosis, immunotherapy response, and candidate drugs in patients treated with transarterial chemoembolization (TACE).
He N, Zhao W, Tian W, Wu Y, Xu J, Lu Y
Discov Oncol. 2024; 15(1):271.
PMID: 38976093
PMC: 11231123.
DOI: 10.1007/s12672-024-01116-8.
IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation.
Roberts B, Li D, Somerville C, Matta B, Jha V, Steinke A
Sci Rep. 2024; 14(1):15557.
PMID: 38969706
PMC: 11226449.
DOI: 10.1038/s41598-024-66168-w.
Bioinformatics Analysis and Experimental Verification Define Different Angiogenesis Subtypes in Endometrial Carcinoma and Identify a Prognostic Signature.
Zhang Q, Yao Y, Yu Z, Zhou T, Zhang Q, Li H
ACS Omega. 2024; 9(24):26519-26539.
PMID: 38911819
PMC: 11190931.
DOI: 10.1021/acsomega.4c03034.
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.
Ye Z, Cheng P, Huang Q, Hu J, Huang L, Hu G
Front Immunol. 2024; 15:1388176.
PMID: 38840908
PMC: 11150710.
DOI: 10.3389/fimmu.2024.1388176.
Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
Zhang M, Sun Q, Han Z, Qin X, Gao T, Xu Y
Heliyon. 2024; 10(10):e30877.
PMID: 38774325
PMC: 11107247.
DOI: 10.1016/j.heliyon.2024.e30877.